MedTrace Logo

Adherence Monitoring in Ambulatory Hypertensive Patients

NCT05215652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2023-04-27

No results posted yet for this study

Summary

Hypertension is a major risk factor for stroke, ischaemic heart disease, and kidney disease. One major cause for uncontrolled blood pressure in spite of prescribed pharmacotherapy was found to be non-adherence including erratic use of prescribed medication.

General practitioners (GP) face limitations when a guideline-conform therapy fails. A new tool to measure and assess medication adherence could be useful to identify patients who are not using medicine as prescribed. This provides new opportunities for patient-specific recommendations and adjustments of treatment.

Our aim is to assess the usefulness of the adherence package AMoPac to identify non-adherence in hypertensive patients nonresponding to treatment in daily practice.

Conditions

Interventions

OTHER

adherence monitoring package (AMoPac)

AMoPac is a tool that consists of * an electronic monitoring device, * data management and data analysis, * feedback on patient's performance, * clinical-pharmaceutical evaluation of medication adherence, * transmission of an adherence report.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2023-04-17
Completion
2023-04-17

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05215652 on ClinicalTrials.gov